Sopharma Trading AD (XBUL:SFT) COGS-to-Revenue : 0.89 (As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Sopharma Trading AD COGS-to-Revenue?

Sopharma Trading AD's Cost of Goods Sold for the three months ended in Sep. 2023 was лв358 Mil. Its Revenue for the three months ended in Sep. 2023 was лв402 Mil.

Sopharma Trading AD's COGS to Revenue for the three months ended in Sep. 2023 was 0.89.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Sopharma Trading AD's Gross Margin % for the three months ended in Sep. 2023 was 11.11%.

Sopharma Trading AD COGS-to-Revenue Historical Data

The historical data trend for Sopharma Trading AD's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma Trading AD COGS-to-Revenue Chart

Sopharma Trading AD Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.92

0.91

0.89

Sopharma Trading AD Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
COGS-to-Revenue	Get a 7-Day Free Trial															0.89	0.89	0.88	0.88	0.89

Sopharma Trading AD COGS-to-Revenue Calculation

Sopharma Trading AD's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1311.603	/	1478.508
	=	0.89

Sopharma Trading AD's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	357.576	/	402.254
	=	0.89

Sopharma Trading AD (XBUL:SFT) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Sopharma Trading AD's Gross Margin % for the three months ended in Sep. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	357.576 / 402.254
	=	11.11 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Sopharma Trading AD COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sopharma Trading AD's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma Trading AD (XBUL:SFT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma Trading AD (XBUL:SFT) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756

Website

http://www.sopharmatrading.bg

Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.

Sopharma Trading AD (XBUL:SFT) Headlines

No Headlines